Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Etelcalcetid (sekundärer hyperparathyreoidismus): addendum zum auftrag A17-25; addendum; auftrag A17-5. [Etelcalcetide (secondary hyperparathyroidism)] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 557. 2017 Indexing Status Subject indexing assigned by CRD MeSH Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32017000461 Date abstract record published 20/12/2017 |